Novel Treatment Could Lead to Functional Control of Hep B Novel Treatment Could Lead to Functional Control of Hep B

Nucleic acid polymers block the release of the hepatitis B surface antigen from hepatocytes, boosting the efficacy of standard antiviral therapy, according to an early clinical trial.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news